@article {Gaitanis2012106,
	title = {The Malassezia genus in skin and systemic diseases},
	journal = {Clinical Microbiology Reviews},
	volume = {25},
	number = {1},
	year = {2012},
	note = {cited By (since 1996)49},
	pages = {106-141},
	abstract = {In the last 15 years, the genus Malassezia has been a topic of intense basic research on taxonomy, physiology, biochemistry, ecology, immunology, and metabolomics. Currently, the genus encompasses 14 species. The 1996 revision of the genus resulted in seven accepted taxa: M. furfur, M. pachydermatis, M. sympodialis, M. globosa, M. obtusa, M. restricta, and M. slooffiae. In the last decade, seven new taxa isolated from healthy and lesional human and animal skin have been accepted: M. dermatis, M. japonica, M. yamatoensis, M. nana, M. caprae, M. equina, and M. cuniculi. However, forthcoming multidisciplinary research is expected to show the etiopathological relationships between these new species and skin diseases. Hitherto, basic and clinical research has established etiological links between Malassezia yeasts, pityriasis versicolor, and sepsis of neonates and immunocompromised individuals. Their role in aggravating seborrheic dermatitis, dandruff, folliculitis, and onychomycosis, though often supported by histopathological evidence and favorable antifungal therapeutic outcomes, remains under investigation. A close association between skin and Malassezia IgE binding allergens in atopic eczema has been shown, while laboratory data support a role in psoriasis exacerbations. Finally, metabolomic research resulted in the proposal of a hypothesis on the contribution of Malassezia-synthesized aryl hydrocarbon receptor (AhR) ligands to basal cell carcinoma through UV radiation-induced carcinogenesis. {\textcopyright} 2012, American Society for Microbiology. All Rights Reserved.},
	keywords = {2 b]carbazole, acquired immune deficiency syndrome, Animalia, antifungal agent, antimicrobial therapy, article, atopic dermatitis, fluconazole, fungus culture, fungus identification, human, Humans, imidazole, indirubin, indolo[3, infection prevention, itraconazole, keto malassezin, ketoconazole, Malassezia, Malassezia caprae, Malassezia cuniculi, Malassezia dermatis, Malassezia equina, Malassezia folliculitis, Malassezia furfur, Malassezia globosa, Malassezia japonica, Malassezia nana, Malassezia obtusa, Malassezia pachydermatis, Malassezia restricta, Malassezia slooffiae, Malassezia sympodialis, Malassezia yamatoensis, malassezin, malassezindole a, molecular epidemiology, Mycoses, nonhuman, onychomycosis, pathogenesis, photodynamic therapy, pityriacitrin, pityrialactone, placebo, psoriasis, seborrheic dermatitis, skin cancer, skin disease, systemic disease, taxonomy, tinea versicolor, toll like receptor 2, unclassified drug},
	issn = {08938512},
	doi = {10.1128/CMR.00021-11},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84855679770\&partnerID=40\&md5=ca30c7853219d9a55ed5fa94cb42faa1},
	author = {Gaitanis, G.a and Magiatis, P.b and Hantschke, M.c and Bassukas, I.D.a and Velegraki, A.d}
}
